Trial intelligence / Profile preview

Meriva for radiation-induced fatigue in breast cancer

NCT01740323Phase 2Completed

Start
May 2015
Primary completion
Jul 2018
Modality
Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of phosphatidylcholine-curcumin complex in fatigue. Started May 2015; status: completed.

02

Drugs

phosphatidylcholine-curcumin complex
03

Conditions

fatigue

Beyond the preview

Go deeper on NCT01740323.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01740323.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call